| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Reg. &Quality Off. | EVP, Chief Regulatory Officer | SVP, CRO
1 company
Tatsis Ourania is an EVP, Chief Reg. &Quality Off. at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $18.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 354 | $425.70 | $150,697.80 | -0.6% | +3.1% | +10.8% | |
| Feb 21, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 360 | $421.77 | $151,837.20 | -0.6% | +5.3% | +14.5% | |
| Feb 20, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 480 | $420.79 | $201,979.20 | -0.8% | +6.0% | +12.2% | |
| Feb 12, 2024 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 314 | $420.24 | $131,955.36 | -0.5% | +2.7% | +8.8% | |
| Aug 23, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 2,500 | $355.00 | $887,500.00 | -4.9% | +1.2% | +36.9% | |
| Aug 10, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 5,750 | $345.79 | $1,988,292.50 | -10.1% | +8.5% | +34.9% | |
| Feb 27, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 354 | $287.48 | $101,768.23 | -0.2% | +13.2% | +49.9% | |
| Feb 21, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 480 | $293.75 | $141,001.58 | -0.2% | +16.2% | +43.5% | |
| Feb 14, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 320 | $298.52 | $95,526.51 | - | +16.1% | +39.2% | |
| Feb 13, 2023 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Chief Reg. &Quality Off. | Sell | 275 | $298.99 | $82,222.87 | - | +16.5% | +39.1% |